<bill session="115" type="h" number="2557" updated="2019-04-18T16:09:08Z">
  <state datetime="2017-10-04">REPORTED</state>
  <status>
    <unknown datetime="2017-10-04"/>
  </status>
  <introduced datetime="2017-05-19"/>
  <titles>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of certain DNA Specimen Provenance Assay clinical diagnostic laboratory tests.</title>
    <title type="short" as="reported to house">Prostate Cancer Misdiagnosis Elimination Act of 2017</title>
    <title type="short" as="reported to house">Prostate Cancer Misdiagnosis Elimination Act of 2017</title>
    <title type="short" as="introduced">Prostate Cancer Misdiagnosis Elimination Act of 2017</title>
    <title type="short" as="introduced">Prostate Cancer Misdiagnosis Elimination Act of 2017</title>
    <title type="display">Prostate Cancer Misdiagnosis Elimination Act of 2017</title>
  </titles>
  <sponsor bioguide_id="B001275"/>
  <cosponsors>
    <cosponsor bioguide_id="B001284" joined="2017-09-13"/>
    <cosponsor bioguide_id="C001072" joined="2017-05-19"/>
    <cosponsor bioguide_id="M001190" joined="2017-05-19"/>
    <cosponsor bioguide_id="P000604" joined="2017-05-19"/>
    <cosponsor bioguide_id="R000515" joined="2017-05-19"/>
    <cosponsor bioguide_id="W000813" joined="2017-07-28"/>
  </cosponsors>
  <actions>
    <action datetime="2017-05-19">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-05-19" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2017-05-19">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2017-05-26">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2017-06-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2017-09-13">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2017-09-13">
      <text>Forwarded by Subcommittee to Full Committee by Voice Vote .</text>
    </action>
    <action datetime="2017-10-04">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2017-10-04" state="REPORTED">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
    </calendar>
    <action datetime="2017-12-06">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-449, Part I.</text>
    </action>
    <action datetime="2017-12-06">
      <text>Committee on Ways and Means discharged.</text>
    </action>
    <calendar datetime="2017-12-06" calendar="Union" number="331">
      <text>Placed on the Union Calendar, Calendar No. 331.</text>
    </calendar>
  </actions>
  <committees>
    <committee subcommittee="" code="HSWM" name="House Ways and Means" activity="Discharged, Referral"/>
    <committee subcommittee="Health" code="HSWM02" name="House Ways and Means" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="115" relation="unknown" number="2067"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Cancer"/>
    <term name="Genetics"/>
    <term name="Government information and archives"/>
    <term name="Health information and medical records"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
  <summary date="2017-12-06T14:01:35Z" status="Reported to House amended, Part I">Prostate Cancer Misdiagnosis Elimination Act of 2017 This bill provides&#160;for Medicare&#160;coverage of&#160;a DNA Specimen Provenance Assay clinical diagnostic laboratory test&#160;following a positive prostate cancer biopsy.</summary>
  <committee-reports>
    <report>H. Rept. 115-449</report>
  </committee-reports>
</bill>
